Computational Biology Market is Anticipated to Expand at a CAGR of 21.3% by 2026: Grand View Research, Inc.

3-Aug-2019: The global computational biology market size is expected to reach USD 13.6 billion by 2026, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 21.3% during the forecast period. Rise in clinical studies in pharmacokinetics and pharmacogenomics for novel drug delivery and increase in the application of computational biology for bioinformatics R&D programs for the population based sequencing studies are fueling the market growth.

Rising use of computational tools in genomics, epi-genomics, proteomics, and meta-genomics to understand 3D protein structural analysis, protein-protein interactions, and gene sequencing and expression studies coupled with increasing research activities in drug designing and disease modeling is expected to drive the growth. However, lack of skilled resources to operate computational tools is expected to restrain the growth of the computational biology market during the forecast period.

Many pharmaceutical companies are seeking funding from angel investors. For instance, in February 2019, StemoniX Inc., the U.S. based provider of product and services for drug discovery and development, received funding of USD 14.40 million from a group of investors. Brightstone Venture Capital was the major financer and was later joined by Crescent Ridge Partners, Alumni Ventures Group, and Mayo Clinic. Similarly, in the same month, U.S. based Buffalo Niagara Medical Campus received funding of USD 5.0 million to speed up the discovery of new drugs. With this finding, the research institute is planning to procure and install drug discovery research instruments and other drug discovery platforms.

In depth research report on Computational Biology Market

https://www.grandviewresearch.com/industry-analysis/computational-biology-market

Further key findings from the report suggest:

·       Cellular and biological simulation is expected to expand at the fastest CAGR of over 15.0% over the forecast period. The shift in sequencing studies towards further analysis of the nature of various biological proteins as a part of the development of personalized medicine, is projected drive the growth

·       Drug discovery and disease modelling applications led the market, accounting for 38.0% of the global market in terms of revenue in 2018. The factors responsible for this growth are extensive drug pipelines for the global drug manufacturing firms

·       North America was the largest regional market, accounted for more than 45.0% of the global revenue in 2018. Increase in research activities for drug discovery processes and innovations in biological computation tools are anticipated to drive the growth

·       Asia Pacific is anticipated to witness the fastest of around CAGR of 23.0% during the forecast period, due to increasing expenditure in the clinical studies for the pharmaco-kinetics and pharmaco-genomics

·       Some of the players operating in the computational biology market include Chemical Computing Group Inc.; Compugen Ltd.; Simulation Plus Inc.; Genedata AG; Certara; Insilico Biotechnology AG; Accelrys; Rhenovia Pharma SAS; Entelos; Nimbus Discovery LLC; and Rhenovia Pharma SAS.

Grand View Research has segmented the global computational biology market based on application, service, end use, and region:

Computational Biology Application Outlook (Revenue, USD Million 2015 - 2026)

·       Cellular & Biological Simulation

o   Computational Genomics

·       Databases

·       Infrastructure/Hardware

·       Software & Services

·       Computational Proteomics

·       Pharmacogenomics

·       Others (Transcriptomics/Metabolomics)

·       Drug Discovery & Disease Modelling

·       Target Identification

·       Target Validation

·       Lead Discovery

·       Lead Optimization

·       Preclinical Drug Development

·       Pharmacokinetics

·       Pharmacodynamics

·       Clinical Trials

·       Phase I

·       Phase II

·       Phase III

·       Human Body Simulation Software

Computational Biology Services Outlook (Revenue, USD Million 2015 - 2026)

·       In-house

·       Contract

Computational Biology End-use Outlook (Revenue, USD Million 2015 - 2026)

·       Academics

·       Industry

·       Commercial

Browse more research reports of this category:

https://www.grandviewresearch.com/industry/healthcare-it

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For more market analysis reports, please visit: http://www.grandviewresearch.com/

Medical Billing Outsourcing Market Size Worth $19.7 Billion By 2026: Grand View Research, Inc.

27-May-2019: The global medical billing outsourcing market size is projected to reach USD 19.7 billion by 2026 expanding at a CAGR of 11.8%, based on a new report by Grand View Research, Inc. Large amount of medical code representation for diagnosis and treatment coupled with the presence of multiple payers renders medical billing an intricate part of any medical practice, posing significant challenges. Currently, the healthcare system is witnessing a subsequent rise in outsourcing of medical billing services by hospitals and physicians due to obligatory implementation of complex ICD-10 coding system, increasing healthcare costs, and federal mandate to implement Electronic Medical Records (EMR) to maintain reimbursement levels.

Furthermore, clinics/physician offices are gradually outsourcing their revenue management to cut unnecessary costs and prevent the burden of managing an administrative team to ensure effective handling of in-house billing functions. In addition, multispecialty medical groups are implementing consolidation requiring EHR integration and building large healthcare networks. This integration creates a need for Revenue Cycle Management (RCM), which, in turn, demands additional expertise and trained personnel to manage the same. Thus, consolidation of large healthcare practices is also expected to be a one of the factors fueling the market growth.

In depth research report on Medical Billing Outsourcing Market

https://www.grandviewresearch.com/industry-analysis/medical-billing-outsourcing-market

Further key findings from the study suggest:

·       In-house segment accounted for the largest market share in 2018. However, outsourced medical billing is expected to be the largest and fastest-growing segment in future

·       Front-end services led the market in 2018. However, middle-end services segment is expected to register the highest CAGR of 12.4% over the forecast period

·       Hospitals accounted for the largest market share of the medical billing outsourcing market in 2018 and is estimated to maintain the dominance even during the forecast years

·       North America held the largest share of the global market. It is projected to expand further as U.S. has witnessed a change in healthcare system with the implementation of ICD-10 coding and pressure from the government to incorporate EMR management system

·

·       Some of the key firms in this industry include Accretive Health, Inc.; Allscripts; Cerner Corporation; EClinicalWorks; Experian Information Solutions, Inc.; GE Healthcare; Genpact; HCL; Kareo; McKesson Corporation; Quest Diagnostics; and The SSI Group, LLC

Grand View Research has segmented the global medical billing outsourcing market on the basis of component, service, end use, and region:

Medical Billing Outsourcing Component Outlook (Revenue, USD Million, 2015 - 2026)

·       In-House

·       Outsourced

Medical Billing Outsourcing Service Outlook (Revenue, USD Million, 2015 - 2026)

·       Front End

·       Middle End

·       Back End

Medical Billing Outsourcing End Use Outlook (Revenue, USD Million, 2015 - 2026)

·       Hospitals

·       Physician Offices

·       Others

Browse more research reports of this category:

https://www.grandviewresearch.com/industry/healthcare-it

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For more market analysis reports, please visit: http://www.grandviewresearch.com/

Infection Surveillance Solutions Market Hit USD 1.0 billion by 2026: Grand View Research, Inc.

1-April-2019: The global infection surveillance solutions market size is poised to reach USD 1.0 billion by 2026, according to a new report by Grand View Research, Inc., progressing at a CAGR of 14.3% during the forecast period. Improving healthcare settings worldwide coupled with advancements in healthcare IT infrastructure is projected to play a pivotal role in the growth of the market. Rising prevalence of healthcare associated infections (HAIs) has been one of the critical factors driving the market.

According to HAI Prevalence Survey conducted by the Center for Disease Control and Prevention (CDC), in 2014, around 722,000 cases of HAIs were detected in the U.S hospitals alone. Moreover, according to the California Department of Public Health (CDPH) in 2016, 18,924 HAIs cases were reported in 400 acute care hospitals. In addition, as per facts published by the European Commission (EC), around 25,000 people die in European Union (EU) from antibiotic resistant bacteria. The figure is expected to increase to 10 million deaths per year, if current infection trend continues by 2050.

Rising collaboration and government initiatives are also stimulating the growth of the market. For instance, in January 2018, Indian Council of Medical Research (ICMR) and Pfizer, Inc. signed partnership agreement to introduce anti-microbial resistance stewardship programs. The objective was to scale up AMR surveillance network in India.

In depth research report on Infection Surveillance Solutions Market

https://www.grandviewresearch.com/industry-analysis/infection-surveillance-solutions-market

Further key findings from the report suggest:

·       Surgical site infections emerged as the most promising segment during the forecast period owing to increasing number of surgeries being performed worldwide

·       On the basis of the product and services segment, the on-premise software segment commanded the largest share in the market owing to its increased usage

·       North America dominated the market in 2017. Government programs and rising awareness about infection surveillance are facilitating the dominance of this region during the forecast period

·       Asia Pacific is estimated to witness swift growth during the forecast period due to increasing establishment of hospital chains and huge patient population

·       Few of the key market players are Wolters Kluwer N.V; Gojo Industries; Becton; Dickinson and Company; RL Solutions; Baxter International Inc.; Premier Inc.; and Truven Health Analytics (An IBM Company).

Grand View Research has segmented the global infection surveillance solutions market based on infection type, product and services, end use, and region:

Infection Surveillance Solutions Product and Services Outlook (Revenue, USD Million, 2014 - 2026)

·       Software

·       On-premise

·       Web-based

·       Services

Infection Surveillance Solutions Infection Type Outlook (Revenue, USD Million, 2014 - 2026)

·       Surgical Site Infections (SSI)          

·       Blood Stream Infections (BSI)

·       Urinary Tract Infections (UTI)

·       Others

Infection Surveillance Solutions End Use Outlook (Revenue, USD Million, 2014 - 2026)

·       Long Term Care Facilities    

·       Hospitals

·       Others (Clinics, and Ambulatory Surgical Centers)

Browse more research reports of this category:

https://www.grandviewresearch.com/industry/healthcare-it

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For more market analysis reports, please visit: http://www.grandviewresearch.com/

Oncology Information Systems Market Hit USD 3.4 billion by 2026: Grand View Research, Inc.

8-March-2019: The global oncology information systems market size is expected to reach USD 3.4 billion by 2026, according to a new report by Grand View Research, Inc. It is anticipated to register a CAGR of 8.4% during the forecast period. Increasing prevalence of cancer and several initiatives pertaining to cancer research taken by major players are among the key driving factors for market growth.

Increasing investment in the field of oncology are among the factors expected to drive the oncology information system market over the forecast period. For instance, in 2018, Varian announced the acquisition of Noona Healthcare. Noona’s patient software application will help in capturing cancer patient-reported outcomes and facilitate direct communication with the patients. This acquisition will help Varian to boost its oncology software services. General Atlantic a Connecticut based company invested around USD 200 million for launching OneOncology, a company designed for helping community oncology practices with the technology data, innovation and research by leveraging the scale. Thus, these factors are expected to drive the OIS market growth.

Key players are also taking initiatives for developing more advanced OIS with an aim for bringing improvement in the cancer treatment. For instance, Elekta announced investment in PalabraApps LLC for the development of advanced Elekta Clinical workflow mobility and productivity tools. The tools developed through these investments will provide the customers with solutions, which are fully integrated with the Elekta's Mosaiq OIS for addressing the growing need of enhanced clinical efficiency and quality control. Such initiatives are anticipated to propel the oncology information system market during the forecast period.

 In depth research report on Oncology Information Systems Market

https://www.grandviewresearch.com/industry-analysis/oncology-information-systems-market

Further key findings from the report suggest:

·       In terms of revenue, software segment is estimated to expand at the highest CAGR over the forecast period, attributed to the benefits offered by software, such as streamlining and fine-tuning the patient management and data management processes

·       Medical oncology is expected to register highest CAGR among application segment over the forecast period owing to the factors, such as increasing usage of chemotherapy, targeted therapy, and hormonal therapy

·       Asia Pacific is expected to witness the fastest CAGR over the forecast period. Various government initiatives and increasing healthcare expenditure are anticipated to drive the regional growth

·       Few key players operating in the oncology information systems market are Elekta AB, Varian Medical Systems, Accuray Incorporated, Cerner Corporation, RaySearch Laboratories and Flatiron.

Grand View Research has segmented the global oncology information systems market on the basis of products, services and application:

Oncology Information Systems Products and Services Outlook (Revenue, USD Billion, 2014 - 2026)

·       Software

·       Patient Information Systems

·       Treatment Planning Systems

·       Professional Services

Oncology Information Systems Application Outlook (Revenue USD Billion; 2014 - 2026)

·       Medical Oncology

·       Radiation Oncology

·       Surgical Oncology

Browse more research reports of this category:

https://www.grandviewresearch.com/industry/healthcare-it

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For more market analysis reports, please visit: http://www.grandviewresearch.com/

Laboratory Information Management System (LIMS) Market Size is Likely to Reach USD 2.22 billion by 2025

21-February-2019: The global laboratory information management system (LIMS) market size is likely to reach USD 2.22 billion by 2025, according to a new report by Grand View Research, Inc., rising at a CAGR of 9.1% during the forecast period. Burgeoning trend of laboratory automation is estimated to stoke the growth of the market.

Increasing investments in R&D activities by pharma and biotechnological organizations are providing a significant push to the market. Growing focus on improving efficiency of laboratories is also expected to help the market gain tremendous momentum over the coming years. Rising emphasis on complying with stringent regulations is also encouraging the deployment of laboratory information management systems, as they comply with GDP, GCP, and GMP.

Laboratory information management systems help in ensuring effective management and tracking of data quality, security, end-user billing, patient demographics, and security. being increasingly implemented for bio banking. They also enable improved data sampling and research information integration. As a result, their demand is high in bio-sampling applications. However, limited availability of skilled professional to manage advanced technologies is projected to hamper growth prospects.

 In depth research report on Laboratory Information Management System (LIMS) Market

https://www.grandviewresearch.com/industry-analysis/laboratory-information-management-system-lims-market

Further key findings from the report suggest:

·       The services component segment accounted for the largest revenue share in 2017, owing to rising lab automation, which requires implementation, maintenance, and support.

·       The CRO segment is poised to experience a lucrative CAGR of 9.8% during the forecast period, due to increasing demand for outsourcing LIMS solutions to curb operating cost.

·       North America was the leading revenue contributor in the market in 2017, due to favorable government initiatives, soaring demand for genomic studies, and growing investments in R&D activities by governments

·       Asia Pacific is anticipated to witness remarkable growth during the forecast period due to rising demand for outsourcing and increasing expenditure in the R&D sector. Japan is projected to be a sight of high growth rate in the region

·       Some of the key companies present in the market are Thermo Fisher Scientific, Inc.; Siemens Group SA; LabWare; PerkinElmer Inc.; Abbott Laboratories; and Autoscribe Informatics.

Grand View Research has segmented the global laboratory information management system market on the basis of product, component, end-use, and region:

Laboratory Information Management System Product Outlook (Revenue, USD Million, 2014 - 2025)

·       On Premise

·       Web hosted

·       Cloud based

Laboratory Information Management System Component Outlook (Revenue, USD Million, 2014 - 2025)

·       Software

·       Services

Laboratory Information Management System End-use Outlook (Revenue, USD Million, 2014 - 2025)

·       Life Sciences

·       CROs

·       Petrochemical Refineries & Oil and Gas Industry

·       Chemical Industry

·       Food and Beverage and Agriculture Industries

·       Environmental Testing Laboratories

·       Other Industries (Forensics and Metal & Mining Laboratories)

Browse more research reports of this category:

https://www.grandviewresearch.com/industry/healthcare-it

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For more market analysis reports, please visit: http://www.grandviewresearch.com/